Google is providing support to combat Zika in Brazil and around the world. The company’s philanthropic organization, announced plans to help and team up with UNICEF and other organizations to fight the disease that’s rapidly spreading across the U.S. and other countries. “A volunteer team of Google engineers, designers, and data scientists is helping UNICEF build…
New Delhi, October 11, 2017 : Google’s digital payment app ‘Tez’ that was launched in India on September 18 has been downloaded five million times on Play Store.
Within 24 hours of ‘Tez’ being launched, Google saw nearly 1.8 crore gross merchandise volume (GMV) done with over four lakh active users.
Built on the Indian government-supported Unified Payments Interface (UPI), Tez allows users, free of charge, to make small or big payments straight from their bank accounts.
According to the National Payment Corporation of India (NPCI), the number of transactions on UPI has crossed three crore in September.
The number of transactions on UPI platform increased to 3.07 crore in September as against 1.66 crore in August — an increase of 85.32 per cent.
Of the 3.07 crore transactions, BHIM’s share was 76.03 lakh — a market share of nearly 24.7 per cent.
“Tez” app works in partnership with four Banks — Axis Bank, HDFC Bank, ICICI Bank and State Bank of India — to facilitate the processing of payments across over 50 UPI-enabled banks.
The app was built for India, working on the vast majority of the country’s smartphones and is available in English and seven Indian languages — Hindi, Bengali, Gujarati, Kannada, Marathi, Tamil and Telugu. (IANS)
Roorkee, October 9, 2017 : Dengue and Chikungunya are known to strike fear in the country every year, so much so that the health graph of the city registers a steep rise in these cases. Both of the water-borne diseases, characterized by high fever and pain in the joints, take a toll on our lives. So far, there is no vaccine to immunize people against the spread of the Dengue and Chikungunya virus. However, researchers at IIT-Roorkee have now discovered that a commonly-utilized de-worming drug can be efficiently used for treatments against Chikungunya.
According to a report by PTI, Shailly Tomar, lead researcher and a professor at Indian Institute of Technology (IIT) Roorkee in Uttarakhand was quoted as saying, “Our research has shown that piperazine, a drug existing in the market, is successful in curbing the spread and replication of the Chikungunya virus in a lab setting.”
The drug, Piperazine, is usually used in de-worming treatments against round-words and pinworms. Using their expertise in virology and structure biology, experts have now discovered the anti-viral capabilities of the drug that can potentially prompt new therapies against the fatal, mosquito borne disease.
The researchers are currently testing the molecule on animals, and will consequently take it to clinical trials.
The molecular details uncovered in the study, which has been published in the journal Antiviral Research, will be additionally used to plan piperazine-derivative medications that are more compelling to fight against the Chikungunya virus.
Using X-ray crystallographic technique, in combination with computational science and fluorescence strategies, the researchers discovered that piperazine binds itself with the hydrophobic (water-hating) pocket of capsid protein present in the Chikungunya virus, which can reduce the spread of the virus.
“This pocket is key to the replication of the virus and its spread inside a host. Inhibiting the pocket prevents budding and spread of the virus and can help in treating the virus effectively using existing drugs,” Tomar said.
Chikungunya has become a major public health concern, with an increasing number of people being plagued by the disease every year.
At present, there are no immunizations or anti-viral medications available to cure Chikungunya, and the treatment is focused on mitigating the side effects related with the disease.
Developing a new anti-viral drug molecule can take up to 10 years. To tend to the disease on an immediate basis, Professor Tomar added, “We are looking at repositioning existing, approved drugs and testing these to see if they might inhibit or kill pathogenic viruses.”
San Francisco, Sep 26 (IANS) Instant messaging service WhatsApp has been largely blocked in China, the media reported.
The Open Observatory of Network Interference (OONI), a global observation network for detecting censorship, surveillance and traffic manipulation, suggested on Monday night that Chinese internet service providers started blocking access to WhatsApp on September 23, reports CNN.
Public reports on Twitter indicated that WhatsApp, which is owned by the US-based social media giant Facebook, became inaccessible for some people on September 19.
Over the last few months, there were a number of WhatsApp disruptions in China.
However, WhatsApp has not made an official announcement on the development.
China has already blocked access to a number of internet companies, including Facebook, Instagram, Twitter and Google.
Some people access these services through virtual private networks (VPN), or with tools that disguise internet traffic to circumvent censorship. But the Chinese government has launched a crack down on VPNs this year.
According to Timothy Heath, senior international defence research analyst at the RAND Corporation, the Chinese government does not like that WhatsApp uses strong encryption.
“The government wants to monitor internet communications, and therefore it’s trying to steer its people to use technology that can be accessed and monitored by the government,” Heath told CNN.
Earlier this month, WeChat, a popular chat service in China, notified users of its policies to comply with government requests for information. (ians)